Skip to main content

McKesson (MCK) - Get McKesson Corporation Report was upgraded to "Overweight" from "Neutral" at JPMorgan today.

Shares of the San Francisco-based company that's engaged in delivering pharmaceuticals, medical supplies and healthcare information technology were up about 2% in early morning trading.

JPMorgan analyst Lisa Gill also raised her price target on the shares to $189 from $167.

Scroll to Continue

TheStreet Recommends

The analyst believes additional value should be unlocked from the Change transaction and that the valuation discount versus peers is unwarranted.

Last week McKesson reported fourth-quarter fiscal 2017 adjusted earnings that exceeded analysts' expectations.

Stocks have rebounded following a sharp sell off last week. Jim Cramer believes the rebound is real and gives investors advice on how to play the market going forward.